Neil David Palmisiano MD MS
Hematologic Oncology
Associate Professor of Medical Oncology
Join to View Full Profile
165 Somerset StreetNew Brunswick, NJ 08901
Dr. Palmisiano is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Sidney Kimmel Medical College at Thomas Jefferson University/TJUHFellowship, Hematology and Medical Oncology, 2011 - 2014- Sidney Kimmel Medical College at Thomas Jefferson University/TJUHResidency, Internal Medicine, 2008 - 2011
Lewis Katz School of Medicine at Temple UniversityClass of 2008
Certifications & Licensure
NJ State Medical License 2018 - 2027
PA State Medical License 2008 - 2026
DE State Medical License 2018 - 2023
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EHR Suite, Epic Systems Corporation, 2017
- CMS Meaningful Use Stage 1 Certification Allscripts TouchWorks EHR, Allscripts, 2017
Clinical Trials
- Sirolimus and Azacitidine in Treating Patients With High Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia That is Recurrent or Not Eligible for Intensive Chemotherapy Start of enrollment: 2013 Jul 08
- Study of ADCT-402 in Patients With Relapsed or Refractory B-cell Lineage Acute Lymphoblastic Leukemia (B-ALL) Start of enrollment: 2016 Mar 01
- Venetoclax and Vincristine in Treating Patients With Relapsed or Refractory T-cell or B-cell Acute Lymphoblastic Leukemia Start of enrollment: 2018 Aug 03
Publications & Presentations
PubMed
- Outcomes of older patients with TP53-mutated myeloid neoplasms.Omer Jamy, Mobachir El Kettani, Kashish Shah, Rory M Shallis, Kendall Diebold
Blood Cancer Journal. 2025-10-07 - 1 citationsTransition to Survivorship Care for Adolescents and Young Adults (AYAs) with Acute Leukemia: Provider Perspectives.Daniella N Flores, Scott Moerdler, Neil Palmisiano, Susan K Parsons, Michael E Roth
Journal of Adolescent and Young Adult Oncology. 2025-10-01 - A smart pill bottle and text messaging intervention for promoting medication adherence in patients with chronic myeloid leukemia: a pilot study of txt4 TKI.Kuang-Yi Wen, Neil Palmisiano, Rita Smith, Rachel Slamon, Gina Keiffer
Supportive Care in Cancer. 2025-05-24
Abstracts/Posters
- Single Cell DNA Sequencing Identifies Combinatorial Mutation Patterns and Clonal Architecture in Myeloid MalignanciesNeil Palmisiano, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- OPB-111077 in Combination with Decitabine and Venetoclax for the Treatment of Acute Myeloid LeukemiaNeil Palmisiano, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Authored Content
- IDH Mutated AML: Beyond Enasidenib and Ivosidenib Monotherapy at SOHO 2021September 2021
Press Mentions
Neil Palmisiano, MD, Appointed as Deputy Director of Phase 1 Therapeutics for Hematologic Malignancies at Rutgers Cancer Institute of New JerseyOctober 3rd, 2022- ASH 2023: Tailoring Treatment in AMLDecember 22nd, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
